
Dr. Khalid Saeed Balaraj
Chair of Oncology Service
Tawam Hospital
United Arab Emirates

Dr. Khalid Saeed Balaraj
Chair of Oncology Service , Tawam Hospital | United Arab Emirates
Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Friday, 2022-11-25
Organizing Committee
00:00 - 23:55
Friday, 2023-11-17
Speakers
08:00 - 18:00

Dr. Jawaher Ali Ansari
Chief of Oncology Department
Tawam Hospital
United Arab Emirates

Dr. Jawaher Ali Ansari
Chief of Oncology Department , Tawam Hospital | United Arab Emirates
Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Friday, 2022-11-25
Organizing Committee
00:00 - 23:55
Friday, 2023-11-17
Speakers
08:00 - 18:00
Lectures by this speaker
Friday, 2022-11-25
Panel Discussion
09:40 - 10:00
Sunday, 2022-11-27
Welcome Note
08:30 - 08:32
Sunday, 2022-11-27
Panel Discussion and Q&A’s + Voting
09:50 - 10:00
Sunday, 2022-11-27
Intensifying Therapy Earlier in the Disease Course , Are We Doing Enough to Improve Outcomes? - Supported by Bayer
10:00 - 10:20
Sunday, 2022-11-27
Apalutamide from Clinical Trials to Clinical Practice - Supported by Janssen
10:20 - 10:40
Sunday, 2022-11-27
Padcev® - Evolving landscape in the management of La/mUC - Supported by Astellas
12:30 - 12:50
Sunday, 2022-11-27
Panel Discussion
12:50 - 13:10
Sunday, 2022-11-27
Bladder Cancer Case Based Discussion
15:40 - 16:25
Sunday, 2022-11-27
Updates on the Management of mRCC and Role of Cabozantinib in the 1st line Treatment - Supported by IPSEN
16:25 - 16:45
Friday, 2022-11-25
30 years of Innovation & commitment to enhancing patient experience- Neulastim Onpro - Supported by KyowaKirin
15:40 - 15:50
Sunday, 2022-11-27
Panel Discussion and Q & A
10:40 - 10:50

Mr. Mohammad Mah'D Saleh
Oncology Center Manager
Tawam Hospital
United Arab Emirates

Mr. Mohammad Mah'D Saleh
Oncology Center Manager , Tawam Hospital | United Arab Emirates
Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Friday, 2022-11-25
Organizing Committee
00:00 - 23:55
Lectures by this speaker
Friday, 2022-11-25
Are we Resilient in Cancer Care?
12:00 - 12:20
Friday, 2022-11-25
Panel Discussion- Q&A’s
12:20 - 12:40
Friday, 2022-11-25
CVAD Challenges – Expert Panel Discussion
14:40 - 15:20

Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiotherapy
Tawam Hospital
United Arab Emirates

Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiotherapy , Tawam Hospital | United Arab Emirates
Chief of Radiotherapy - Tawam Hospital
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Lectures by this speaker
Saturday, 2022-11-26
Panel Discussion
15:20 - 15:30

Dr. M Zafar Javed
Chief of Palliative Care Clinics
Tawam Hospital
United Arab Emirates

Dr. M Zafar Javed
Chief of Palliative Care Clinics , Tawam Hospital | United Arab Emirates
Chief of Palliative Care Clinics – Tawam Hospital
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Friday, 2023-11-17
Speakers
08:00 - 18:00

Dr. Muhammad Faisal Khanani
Chief of Hematology/Oncology PEDS
Tawam Hospital
United Arab Emirates

Dr. Muhammad Faisal Khanani
Chief of Hematology/Oncology PEDS , Tawam Hospital | United Arab Emirates
Chief of Hematology/Oncology PEDS – Tawam Hospital
Sessions by this speaker
Friday, 2022-11-25
Scientific Committee
00:00 - 23:55
Friday, 2023-11-17
Speakers
08:00 - 18:00

Dr. Arif Raza Alam
Chief of Hematology
Tawam Hospital
United Arab Emirates

Dr. Arif Raza Alam
Chief of Hematology , Tawam Hospital | United Arab Emirates
Chief of Hematology – Tawam Hospital